BofA raised the firm’s price target on AptarGroup (ATR) to $147 from $142 and keeps a Neutral rating on the shares. Following Q4, the firm trimmed 2026 estimates and rolled valuation assumptions to its revised 2026 estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATR:
- AptarGroup price target raised to $156 from $145 at Baird
- Balanced View on AptarGroup: Solid Underlying Pharma Performance Offset by Near-Term Headwinds and Underwhelming Beauty & Closures, Justifying a Hold Rating
- AptarGroup sees Q1 adjusted EPS $1.13-$1.21, consensus $1.23
- AptarGroup reports Q4 adjusted EPS $1.25, consensus $1.23
- ATR Earnings this Week: How Will it Perform?